Phong Phu Pharmaceutical JSC (HNX:PPP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
18,800
+400 (2.17%)
At close: Mar 3, 2026
0.53%
Market Cap 176.00B
Revenue (ttm) 139.83B
Net Income (ttm) 18.55B
Shares Out 8.80M
EPS (ttm) 1,884.00
PE Ratio 10.62
Forward PE n/a
Dividend 1,500.00 (7.98%)
Ex-Dividend Date Mar 19, 2026
Volume 900
Average Volume 1,367
Open 18,700
Previous Close 18,400
Day's Range 18,600 - 18,800
52-Week Range 17,200 - 23,100
Beta 0.02
RSI 50.21
Earnings Date Jan 23, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health protection food, that are offered in tablets, film-coated, sugar-coated, soft capsules, granules, powder, and other forms. It offers its products for respiratory, spiritual, anti-inflammatory, anti-allergic, digest, cardiovascular, diabetes, liver function, and osteoarthritis, as well as provides vitamins and minerals. Phon... [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 212
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PPP
Full Company Profile

Financial Performance

In 2025, HNX:PPP's revenue was 139.83 billion, an increase of 1.66% compared to the previous year's 137.55 billion. Earnings were 18.55 billion, an increase of 19.34%.

Financial Statements

News

There is no news available yet.